Nat Rev NephrolJClub
A roadmap for therapeutic innovation in paediatric chronic kidney disease.
Nature Reviews Nephrology · · Review
Wan, Shroff + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
An international paediatric CKD therapeutic roadmap identifies key gaps in drug development, trial design, and surrogate endpoints, emphasizing urgent coordinated innovation across discovery-to-translation.
- Why it matters: Paediatric chronic kidney disease remains underserved despite supportive care advances, and adult CKD breakthroughs have highlighted regulatory and therapeutic challenges specific to children. This creates a need to align stakeholders to accelerate development for a high-burden, life-altering condition.
- What they did: The roadmap was produced by an international, multidisciplinary collaboration spanning paediatric and adult nephrologists, pharmacologists, biostatisticians, regulatory and HTA experts, industry, and patient advocates. It summarizes the current landscape and outlines constraints in clinical trial design, including surrogate end-point qualification and adaptive methodologies.
- The result: It calls for coordinated global efforts to speed therapeutic innovation and better address unmet needs in paediatric CKD. The document frames surrogate endpoints and innovative, adaptive trial approaches as critical to enabling progress.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.